Izotropic Corporation
IZOZF · OTC
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.06 | 0.06 | 0.11 | -0.63 |
| FCF Yield | -4.29% | -8.96% | -19.45% | -15.97% |
| EV / EBITDA | -8.10 | -5.39 | -3.63 | -4.76 |
| Quality | ||||
| ROIC | 100.40% | 87.51% | 556.82% | -383.51% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.20 | 0.38 | 0.58 | 0.72 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -7.38% | 82.03% | 31.03% | -55.39% |
| Safety | ||||
| Net Debt / EBITDA | -1.16 | -1.26 | -0.38 | -0.03 |
| Interest Coverage | -7.35 | -6.19 | -17.68 | -318.23 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -11,072.14 | -13,543.66 | -20,077.71 |